Data from clinical registries can ID novel drug interactions

Data from clinical registries can ID novel drug interactions

Data mining can be used to discover unknown drug-drug interactions in cardiovascular medicine, according to a study published online Nov. 8 in Circulation: Cardiovascular Quality and Outcomes.... read more

Cellular Mechanisms of Prevention of Ischemia-Reperfusion Injury

Cellular Mechanisms of Prevention of Ischemia-Reperfusion Injury

Ischemic preconditioning is the phenomenon whereby brief periods of sublethal ischemia protect against a subsequent, more prolonged, ischemic insult.... read more

Impaired recycling of mitochondria in autism?

Impaired recycling of mitochondria in autism?

The new study shows that autophagy is defective in TSC. The scientists further showed that two existing classes of drugs counter the defect: the epilepsy drug carbamazepine, and drugs known as mTOR inhibitors.... read more

HDAC inhibitors show promise against cancer stem cells

HDAC inhibitors show promise against cancer stem cells

A group of researchers, led by scientists at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine, has shown that histone deacetylase (HDAC) inhibitors have the potential to eliminate... read more

Bifunctional drug could treat tumors resistant to current mTOR inhibitors

Bifunctional drug could treat tumors resistant to current mTOR inhibitors

The first known bifunctional inhibitor for the mechanistic target of rapamycin (mTOR) protein was developed to overcome current known mechanisms of tumor resistance to mTOR inhibitors.... read more